Coronary Artery Anomalies and Their Impact on the Feasibility of Percutaneous Pulmonary Valve Implantation

被引:0
作者
Anja Hanser
Jörg Michel
Andreas Hornung
Ludger Sieverding
Michael Hofbeck
机构
[1] University Children’s Hospital Tuebingen,Department of Pediatric Cardiology
来源
Pediatric Cardiology | 2022年 / 43卷
关键词
Congenital heart disease; Percutaneous pulmonary valve implantation; Congenital coronary artery anomaly;
D O I
暂无
中图分类号
学科分类号
摘要
One of the major obstacles preventing successful percutaneous pulmonary valve implantation (PPVI) is related to the close proximity of coronary artery branches to the expected landing zone. The aim of this study was to assess the frequency of coronary artery anomalies (CAAs) especially those associated with major coronary branches crossing the right ventricular outflow tract (RVOT) and to describe their relevance for the feasibility of percutaneous pulmonary valve implantation (PPVI). In our retrospective single-center study 90 patients were evaluated who underwent invasive testing for PPVI in our institution from 1/2010 to 1/2020. CAAs were identified in seven patients (8%) associated with major branches crossing the RVOT due to origin of the left anterior descending (LAD) or a single coronary artery from the right aortic sinus. In 5/7 patients with CAAs balloon testing of the RVOT and selective coronary angiographies revealed a sufficiently large landing zone distal to the coronary artery branch. While unfavorable RVOT dimensions prevented PPVI in one, PPVI was performed successfully in the remaining four patients. The relatively short landing zone required application of the “folded” melody technique in two patients. All patients are doing well (mean follow-up 3 years). CAAs associated with major coronary branches crossing the RVOT can be expected in about 8% of patients who are potential candidates for PPVI. Since the LAD crossed the RVOT below the plane of the pulmonary valve successful distal implantation of the valve was possible in 4/7 patients. Therefore these coronary anomalies should not be considered as primary contraindications for PPVI.
引用
收藏
页码:8 / 16
页数:8
相关论文
共 229 条
  • [11] McElhinney DB(2015)A new percutaneous pulmonary valve implantation technique for complex right ventricular outflow tracts: the "folded melody valve" Catheter Cardiovasc Interv 85 604-91
  • [12] Cheatham JP(2018)Early outcomes of percutaneous pulmonary valve implantation using the Edwards SAPIEN XT transcatheter heart valve system Int J Cardiol 250 86-834
  • [13] Hellenbrand WE(2019)Intermediate outcomes of transcatheter pulmonary valve replacement with the Edwards Sapien 3 valve—German experience Expert Rev Med Devices 16 829-596
  • [14] Zahn EM(2020)Munich comparative study: prospective long-term outcome of the transcatheter melody valve versus surgical pulmonary bioprosthesis with up to 12 years of follow-up Circ Cardiovasc Interv 13 e008963-303
  • [15] Jones TK(2015)Pictorial review of coronary anomalies in tetralogy of Fallot J Cardiovasc Comput Tomogr 9 593-995
  • [16] Berman DP(2020)Utility of CT angiography for the prediction of coronary artery compression in patients undergoing transcatheter pulmonary valve replacement World J Pediatr Congenit Heart Surg 11 295-135
  • [17] Vincent JA(2013)Off-label use of percutaneous pulmonary valved stents in the right ventricular outflow tract: time to rewrite the label? Catheter Cardiovasc Interv 81 987-1650
  • [18] McElhinney DB(2015)Percutaneous pulmonary valve implantation for free pulmonary regurgitation following conduit-free surgery of the right ventricular outflow tract Int J Cardiol 186 129-113
  • [19] Giugno L(2018)Safety and feasibility of melody transcatheter pulmonary valve replacement in the native right ventricular outflow tract: a multicenter pediatric heart network scholar study JACC Cardiovasc Interv 11 1642-821
  • [20] Faccini A(2019)Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes Transl Pediatr 8 107-1130